Using auricular nerve stimulation to help adolescents with self-injury
Official title: Pilot Study on the Acceptability of Auricular Vagus Nerve Neurostimulation for the Prevention of Non-suicidal Self-injury Recurrence in Adolescents
Run by Centre Hospitalier Régional Metz-Thionville · NCT06433583 · Data updated 2026-11-12
This study is testing if a new type of nerve stimulation can help teenagers who hurt themselves feel better and find it acceptable as a treatment option.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 18 Years |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Centre Hospitalier Régional Metz-Thionville Academic / other |
| Locations | 2 sites (Metz, Grand Est and 1 other locations) |
| Status | Recruiting |
| Started | November 28, 2024 |
| Main results expected | November 28, 2028 |
| Study ends | November 28, 2028 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT06433583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 13 to 17 who have been diagnosed with non-suicidal self-injury disorder.
✕Probably not a fit
Patients with contraindications to taVNS, such as certain cardiac conditions or active implantable devices, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study investigates the acceptability of transcutaneous auricular vagus nerve stimulation (taVNS) in adolescents aged 13 to 17 who engage in non-suicidal self-injury (NSSI). The study aims to explore how this neurostimulation technique can influence the autonomic nervous system and potentially alleviate symptoms associated with NSSI. Given the rising prevalence of NSSI among adolescents, especially during the COVID-19 pandemic, this approach seeks to provide an alternative to traditional psychiatric interventions, which are often limited in availability and efficacy. Participants will receive taVNS treatment while their responses and experiences will be monitored to assess the intervention's acceptability.
Why it matters
Potential benefit: If successful, this approach could offer a novel, non-invasive treatment option for adolescents struggling with self-injury behaviors.
How similar studies have gone: While taVNS has been studied for various conditions, this specific application in adolescents with NSSI is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents aged between 13 and 17 years old * Patients with NSSI disorder as defined by DSM-5 * Patient affiliated to a social security scheme * Patient who parents or guardians have signed a free and informed consent form * Patient able to understand neurostimulation instructions Exclusion Criteria: * Contraindication to taVNS: * Malformation, skin pathology of the external ear. (piercings in the area concerned must be removed during the neurostimulation session). * Children with sleep apnea syndrome treated with NIV (non-invasive ventilation) * Presence of epileptic seizures * Proven cardiac pathology on the advice of the attending cardiologist * History of venous or arterial thrombosis * Adolescent with pacemaker or defibrillator * Adolescent with an active implantable device * Pregnancy (based on anamnestic criteria, checked by blood test if necessary) * Patients with psychotic episodes, confusional states or severe neurodevelopmental disorders * Patients with an allergic skin reaction to silicone (component of the ear electrode) * Patients with a cochlear implant on the stimulation side * Pregnant or breast-feeding women * Minor under guardianship * Minor under judicial measure or sanction
Where it's running
-
Centre Médico-Psychologique adolescents - CHR Metz-Thionville
Thionville, France Recruiting -
Etablissement Publique de Santé Mentale (EPSM) Metz-Jury
Metz, Grand Est, France Not yet recruiting
Study contacts
- Principal investigator: Dorin SINDILA, MD — CHR Metz Thionville
- Study coordinator: Justine GRIGORCEA, MD
- Email: justine.grigorcea@chr-metz-thionville.fr
- Phone: 00333 82 88 15 03
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Brief Suicidal Crisis Prevalence in Psychiatric Settings
This observational study tests how common a brief suicidal crisis (under 24 hours) is among adults seen by psychiatrists in Clermont-Ferrand, France.
-
Brief Case Management to Help Personal Recovery after Involuntary Psychiatric Admission
This trial tests whether a Brief Case Management approach helps people who were involuntarily admitted to a psychiatric hospital recover personally and avoid another involuntary readmission.
-
Sailing to support psychosocial rehabilitation
This project tries sailing activities alongside usual care to see if they help adults with psychiatric or neurodevelopmental disorders who live in Seine-Saint-Denis.
-
Group classes to support independent living for people with severe psychiatric disorders
This project will try group psychoeducation sessions for people with severe psychiatric disorders and their carers to see if it helps them live more independently at home.
-
Adapted HOPE workshop to reduce burnout for gynecologic oncology clinicians
This program will test whether an adapted HOPE workshop can help gynecologic oncology clinicians reduce stress and burnout.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.